Michele Zagnoni PhD

Dr. Michele Zagnoni leads a multidisciplinary research group focussed on the development of microfluidic technologies for healthcare applications, including fundamental biological research, drug screening, precision medicine, organ-on-a-chip and synthetic biology (www.zagnonilab.com). Michele has extensive expertise in bridging microfluidic technology to biological applications in the areas of cancer research, neuroscience, ion channel characterization, and drug screening.

He has 13 years of interdisciplinary research expertise in microfabrication of microfluidic devices, lab-on-a-chip techniques, single-cell and cell network analysis on-chip, and miniaturized bioassay development. He has co-authored 80+ peer-reviewed papers and conference proceedings. He is the Chief Scientific Officer of ScreenIn3D, a company that provides drug screening services based on microfluidics and 3D cell culture.